(Q41474933)

1 October 2017

title

Treatment of obstetric and gynecologic infections with cefamandole (English)

1 reference

https://api.crossref.org/works/10.1016/0002-9378(79)90005-X

1 May 2023

1

F G Cunningham

1 reference

1 October 2017

2

L C Gilstrap

1 reference

1 October 2017

S. S. Kappus

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A426015

1 May 2023

language of work or name

English

0 references

publication date

1 March 1979

1 reference

1 October 2017

15 March 1979

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=426015

full work available at URL

1 May 2023

https://api.elsevier.com/content/article/PII:000293787990005X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9378(79)90005-X

https://api.elsevier.com/content/article/PII:000293787990005X?httpAccept=text/plain

1 May 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9378(79)90005-X

American Journal of Obstetrics and Gynecology

1 May 2023

published in

1 reference

1 October 2017

volume

133

1 reference

1 October 2017

issue

6

1 reference

1 October 2017

page(s)

602-610

1 reference

Infections in obstetrics and gynecology. New developments in treatment.

1 October 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0002-9378(79)90005-X

Anaerobic infections of the female genital tract: Bacteriologic and therapeutic aspects

1 May 2023

2

1 reference

https://api.crossref.org/works/10.1016/0002-9378(79)90005-X

Anaerobic Bacterial Infections of the Female Genital Tract

1 May 2023

3

1 reference

https://api.crossref.org/works/10.1016/0002-9378(79)90005-X

1 May 2023

Anaerobic infections. 1.

5

1 reference

https://api.crossref.org/works/10.1016/0002-9378(79)90005-X

Anaerobic infections of the female genital tract: prospects and perspectives

1 May 2023

6

1 reference

https://api.crossref.org/works/10.1016/0002-9378(79)90005-X

Evaluation of Tetracycline or Penicillin and Ampicillin for Treatment of Acute Pelvic Inflammatory Disease

1 May 2023

7

1 reference

https://api.crossref.org/works/10.1016/0002-9378(79)90005-X

Carbenicillin therapy of anaerobic infections

1 May 2023

8

1 reference

https://api.crossref.org/works/10.1016/0002-9378(79)90005-X

Cefamandole, a cephalosporin antibiotic with an unusually wide spectrum of activity

1 May 2023

10

1 reference

https://api.crossref.org/works/10.1016/0002-9378(79)90005-X

Cefamandole: in vitro and clinical pharmacokinetics

1 May 2023

11

1 reference

https://api.crossref.org/works/10.1016/0002-9378(79)90005-X

In vitro activity and clinical pharmacology of cefamandole in comparison to cephalothin

1 May 2023

12

1 reference

https://api.crossref.org/works/10.1016/0002-9378(79)90005-X

The bacterial pathogenesis of acute pelvic inflammatory disease

1 May 2023

19

1 reference

https://api.crossref.org/works/10.1016/0002-9378(79)90005-X

Anaerobic infections of the female genital tract

1 May 2023

22

1 reference

https://api.crossref.org/works/10.1016/0002-9378(79)90005-X

Antibiotic Therapy of Obstetric and Gynecologic Infections

1 May 2023

23

1 reference

https://api.crossref.org/works/10.1016/0002-9378(79)90005-X

Life-threatening infections in pregnancy

1 May 2023

24

1 reference

https://api.crossref.org/works/10.1016/0002-9378(79)90005-X

Bactericidal Activity of Five Antimicrobial Agents against Bacteroides fragilis

1 May 2023

26

1 reference

https://api.crossref.org/works/10.1016/0002-9378(79)90005-X

Bacteremic Bacteroides infections

1 May 2023

27

1 reference

https://api.crossref.org/works/10.1016/0002-9378(79)90005-X

In Vitro Antimicrobial Susceptibility of Anaerobic Bacteria Isolated from Clinical Specimens

1 May 2023

28

1 reference

https://api.crossref.org/works/10.1016/0002-9378(79)90005-X

In vitro susceptibility of bacteroides strains to tetracycline, chloramphenicol, doxycycline, and clindamycin

1 May 2023

29

1 reference

https://api.crossref.org/works/10.1016/0002-9378(79)90005-X

Comparative Susceptibility of Anaerobic Bacteria to Minocycline, Doxycycline, and Tetracycline

1 May 2023

30

1 reference

https://api.crossref.org/works/10.1016/0002-9378(79)90005-X

Cefamandole in treatment of peritonitis

1 May 2023

31

1 reference

https://api.crossref.org/works/10.1016/0002-9378(79)90005-X

Clinical Pharmacology of Cefamandole as Compared with Cephalothin

1 May 2023

32

1 reference

https://api.crossref.org/works/10.1016/0002-9378(79)90005-X

Pharmacological Studies with Cefamandole in Human Volunteers

1 May 2023

33

1 reference

https://api.crossref.org/works/10.1016/0002-9378(79)90005-X

Comparison of the pharmacokinetics of cefamandole and other cephalosporin compounds

1 May 2023

34

1 reference

https://api.crossref.org/works/10.1016/0002-9378(79)90005-X

Clinical evaluation of cefamandole nafate

1 May 2023

35

1 reference

https://api.crossref.org/works/10.1016/0002-9378(79)90005-X

Antimicrobial Therapy of Experimental Intraabdominal Sepsis

1 May 2023

36

1 reference

https://api.crossref.org/works/10.1016/0002-9378(79)90005-X

Pharmacokinetics of Cephalosporins in Patients with Normal or Reduced Renal Function

1 May 2023

37

1 reference

https://api.crossref.org/works/10.1016/0002-9378(79)90005-X

1 May 2023

Identifiers

0 references

1 reference